Overview on chirality and applications of stereo-selective dissolution testing in the formulation and development work

Dissolution Technologies

Volumn 10, Issue 3, 2003, Pages 16-20

  Gohel, Mukesh C ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMETHYLPHENIDATE; ESOMEPRAZOLE;

ARTICLE; CHIRALITY; CRYSTAL STRUCTURE; DATA ANALYSIS SOFTWARE; DISSOLUTION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STABILITY; FOOD AND DRUG ADMINISTRATION; PERFORMANCE; PHARMACEUTICAL CARE; RACEMIC MIXTURE; STEREOISOMERISM;

EID: 50449110110     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT100303P16     Document Type: Article

References (18)

1. Guidance for Industry: Stereochemical issues in Chiral Drug Development, Therapeutic Products Programme Guidance Document, Canada 2000, www. hcsc. ca/hpb-dgps/therapeuth.
2. Rentsch, K. M., " The importance of stereoselective determination of drugs in the clinical laboratory." J. Biochem. Biophys. Methods, 54(1-3), 1-9, 2002.
3. Stephen, C. S., " Chiral Pharmaceuticals." Chemical and Engineering News, 79(40), 79-97, 2001.
4. http: //www. imc-global. com
5. Houlton, S., " Chiral switches lead to blockbuster drugs.," Manuf. Chemist, 73(1), 28-30, 2002.
6. Jamali, F., Mehvar, R., and Pasutto, F. M., " Enantioselective aspects of drug action and disposition: therapeutic pitfalls." J. Pharm. Sci., 78(9), 693-713, 1989.
7. Tao, W. A. and Cooks, R. G., " Chiral analysis by MS." Analytical Chemistry, 75(1), 25A-31A, 2003.
8. Lou, W. J., " Chiral Resolutions: Past, Present and Future.," The Ramanbhai Foundation First International Symposium in Recent Trends in Pharmaceutical Sciences, Symposium Companion, Ahmedabad, India, p. 35, January 2003.
9. Solinis, M. A., De La Cruz, Y., Calvo, B., Hernandez, R. M., Cascon, A. R., Coni, I., Gurruchaga, M. D., and Pedraz, J. L., " Release of salbutamol sulphate and ketoprofen enantiomers from matrices containing HPMC and cellulose derivatives." Chirality, 14(10), 806-813, 2002.
10. Srichana, T. and Suedee, R., " Evaluation of stereoselective dissolution of racemic salbutamol matrices prepared with commonly used excipients and 1H-NMR study." Drug Develop. Ind. Pharmacy, 27(5), 457-464, 2001.
11. Suedee, R., Srichana, T. and Martin, G. P., " Evaluation of matrices containing molecularly imprinted polymers in the enantioselective controlled delivery of beta blockers." J. Controlled Release, 66(2-3), 135-147, 2000.
12. Janjikhel, R. K. and Adeyeye, C. M., " Dissolution of ibuprofen enantiomers from co-precipitates and suspensions containing chiral excipients." Pharm. Dev. Technology, 4(1), 9-17, 1999.
13. Yonemochi, E., Yoshihashi, Y. and Terada, K., " Quantitative relationship between stability, initial dissolution rate and heat of solution of chiral drugs." Pharm. Research, 17(1), 90-93, 2000.
14. Bui, T. H., Fernandez, C., Vu K., Nguyen, K. H. and Thuillier, A., Farinotti, R., Arnaud, P. and Gimenez, F., " Stereospecific versus nonstereoselective assessment for the bioequivalence of two formulations of racemic chlorpheniramine.," Chirality, 12(8), 599-605, 2000.
15. Polli, J. E., " IVIVR versus IVIVC," Dissolution Technologies, 7(3), 6-8, 2000.
16. http: //www. fda/gov/guidances/stereo. html
17. Pomponio, R., Gotti, R., Bertucci, C. and Cavrini, V., "Evidences of cyclodextrin mediated enantioselective photodegradation of rac-nicrdipine by capillary electrophoresis." Electrophoresis, 22(15), 3243-3250, 2001.
18. Elizabeth B. V., Stability of Pharmaceutical products, Remington: The Science and Practice of Pharmacy, 20th edition, 2000, Lippincott Williams and Wilkins, Maryland USA, p. 986.